| 注册
首页|期刊导航|四川医学|膀胱灌注羟基喜树碱预防浅表性膀胱癌术后复发的临床观察

膀胱灌注羟基喜树碱预防浅表性膀胱癌术后复发的临床观察

吴波

四川医学2012,Vol.33Issue(12):2139-2141,3.
四川医学2012,Vol.33Issue(12):2139-2141,3.

膀胱灌注羟基喜树碱预防浅表性膀胱癌术后复发的临床观察

The effect of intravesical instillation of hydroxycamptothecin to prevent recurrence after surgical treatment of superficial bladder tumor

吴波1

作者信息

  • 1. 郫县人民医院外科,四川成都611730
  • 折叠

摘要

Abstract

Objective To explore clinical effectiveness and safty of hydroxycamplolhecin to prevent recurrence after surgical treatment of superficial bladder tumor. Methods All patients were treated with transurethral electrosurgical excision procedure. The observation group was treated with intravesical instillation of hydroxycamptothecin; and the control group was treated with Mitomycin C. All the patients were followed up for 24 ~36 months, in order to evaluate the recurrence rates and side effects after treatment. Results The recurrence rate of two group patients follow-up of 3 monlhs(2.50% VS 5. 00% ) and follow-up of 6 months(7. 50% VS 10.00% )has no significant difference(P >0.05). The recurrence rate of two group patients follow-up of 12 monlhs( 10. 00% VS 30. 00% ) and follow-up of 24 months (17.50% VS 37.50% ) has statistically significant difference ( P < 0. 05). The side effects rate in observation group is 22. 50% , and 72. 50% in control group, the difference was statistically significant (P <0.05). Conclusion It showed that hydroxycamptothecine intravesical instillation after operation is effective and safty in the prevent of recurrence of superficial bladder tumor.

关键词

羟基喜树碱/丝裂霉素/浅表性膀胱癌/膀胱灌注/化疗

Key words

hydroxycamplothecine/mitomycin C/superficial bladder tumor/intravesical infusion/ chemotherapy

分类

医药卫生

引用本文复制引用

吴波..膀胱灌注羟基喜树碱预防浅表性膀胱癌术后复发的临床观察[J].四川医学,2012,33(12):2139-2141,3.

四川医学

OACSTPCD

1004-0501

访问量0
|
下载量0
段落导航相关论文